|
NL222157A
(enExample)
*
|
1956-12-20 |
|
|
|
|
US5763596A
(en)
*
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
C-4' modified adenosine kinase inhibitors
|
|
WO1994018215A1
(en)
*
|
1993-02-03 |
1994-08-18 |
Gensia, Inc. |
Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
|
|
US5514798A
(en)
*
|
1993-06-02 |
1996-05-07 |
Gilead Sciences, Inc. |
Method and cyclic carbonates for nucleotide analogues
|
|
RU2186569C2
(ru)
|
1996-01-23 |
2002-08-10 |
Ай-Си-Эн ФАРМАСЬЮТИКАЛЗ |
Модуляция экспрессии тн1/тн2 цитокинов рибавирином и аналогами рибавирина в активированных т-лимфоцитах
|
|
US6128582A
(en)
|
1996-04-30 |
2000-10-03 |
Vertex Pharmaceuticals Incorporated |
Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them
|
|
CA2267279A1
(en)
|
1996-10-16 |
1998-04-23 |
Devron Averett |
Monocyclic l-nucleosides, analogs and uses thereof
|
|
CA2266889A1
(en)
|
1996-10-16 |
1998-04-23 |
Guangyi Wang |
Purine l-nucleosides, analogs and uses thereof
|
|
GB9623908D0
(en)
|
1996-11-18 |
1997-01-08 |
Hoffmann La Roche |
Amino acid derivatives
|
|
WO1998022458A1
(en)
|
1996-11-19 |
1998-05-28 |
Icn Pharmaceuticals, Inc. |
Multivalent salts of pyridostigmine and related compounds
|
|
KR20000069658A
(ko)
|
1996-12-27 |
2000-11-25 |
와트 씨 데이빗, 해리 에이 루스제 |
G 풍부 올리고 앱태머 및 면역 반응을 변조시키는 방법
|
|
SI9820003A
(sl)
|
1997-01-17 |
1999-06-30 |
Icn Pharmaceuticals, Inc. |
Zdravljenje bolezni povezano s citokini
|
|
SE506898C2
(sv)
|
1997-03-06 |
1998-02-23 |
Carlo Castro |
Ryggsmörjare för insmörjning av hudkräm på en människokropp
|
|
GB9707659D0
(en)
|
1997-04-16 |
1997-06-04 |
Peptide Therapeutics Ltd |
Hepatitis C NS3 Protease inhibitors
|
|
YU67099A
(sh)
|
1997-06-30 |
2002-06-19 |
Icn Pharmaceuticals Inc. |
Postupak za dobijanje tiazofurina i drugih c-nukleozida
|
|
IL121413A
(en)
|
1997-07-28 |
2000-10-31 |
Green Cloud Ltd |
Method for reducing the accumulation of precipitates and impurities on ultrasonic transducers
|
|
PT1012180E
(pt)
|
1997-08-11 |
2005-04-29 |
Boehringer Ingelheim Ca Ltd |
Analogos de peptidos inibidores da hepatite c
|
|
IL134232A0
(en)
|
1997-08-11 |
2001-04-30 |
Boehringer Ingelheim Ca Ltd |
Hepatitis c inhibitor peptides
|
|
WO1999036074A1
(en)
|
1998-01-15 |
1999-07-22 |
Icn Pharmaceuticals, Inc. |
Use of 8-cl-camp in prevention of restenosis of arterial walls
|
|
US6348587B1
(en)
|
1998-02-25 |
2002-02-19 |
Emory University |
2′-Fluoronucleosides
|
|
US6312662B1
(en)
*
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
|
AU767599B2
(en)
*
|
1998-03-06 |
2003-11-20 |
Metabasis Therapeutics, Inc. |
Novel prodrugs for phosphorus-containing compounds
|
|
GB9806815D0
(en)
|
1998-03-30 |
1998-05-27 |
Hoffmann La Roche |
Amino acid derivatives
|
|
JP4690545B2
(ja)
|
1998-03-31 |
2011-06-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
セリンプロテアーゼ、特にc型肝炎ウイルスns3プロテアーゼの阻害因子
|
|
JP2002516256A
(ja)
|
1998-05-26 |
2002-06-04 |
アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド |
二環式糖成分を有する新規ヌクレオシド
|
|
GB9812523D0
(en)
|
1998-06-10 |
1998-08-05 |
Angeletti P Ist Richerche Bio |
Peptide inhibitors of hepatitis c virus ns3 protease
|
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
|
US6045638A
(en)
|
1998-10-09 |
2000-04-04 |
Atlantic Research Corporation |
Monopropellant and propellant compositions including mono and polyaminoguanidine dinitrate
|
|
JP2002528499A
(ja)
|
1998-10-29 |
2002-09-03 |
ブリストル−マイヤーズ スクイブ カンパニー |
Impdh酵素のインヒビターであるアミノ核誘導化合物
|
|
PL364699A1
(en)
|
1999-01-29 |
2004-12-13 |
Icn Pharmaceuticals, Inc. |
Modulation of immune response by ribavirin
|
|
UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
|
MXPA02000294A
(es)
|
1999-06-25 |
2002-06-21 |
Vertex Pharma |
Profarmacos de carbamatos inhibidores de impdh.
|
|
MXPA02001753A
(es)
|
1999-08-27 |
2002-10-23 |
Ribapharm Inc |
Analogos de nucleosido de pirrolo [2,3-d]pirimidina.
|
|
WO2001018013A1
(en)
*
|
1999-09-08 |
2001-03-15 |
Metabasis Therapeutics, Inc. |
Prodrugs for liver specific drug delivery
|
|
US6518253B1
(en)
|
1999-11-19 |
2003-02-11 |
Robert Tam |
Treatment of viral infections using the L-isomer of ribavirin
|
|
AU5076601A
(en)
|
1999-12-13 |
2001-07-03 |
Icn Pharmaceuticals, Inc. |
Pulmonary delivery of ribavirin or levovirinTM for systemic and quasi-systemic treatment of disease
|
|
JP2003523957A
(ja)
|
1999-12-23 |
2003-08-12 |
アイシーエヌ・ファーマシューティカルズ・インコーポレイテッド |
組成物、並びにl−ヌクレオシド、l−ヌクレオチドおよびそれらのアナログの製造法
|
|
RU2223761C2
(ru)
|
1999-12-27 |
2004-02-20 |
Джапан Тобакко Инк. |
Соединения с конденсированным кольцом и их использование в качестве лекарственных средств
|
|
US6455508B1
(en)
|
2000-02-15 |
2002-09-24 |
Kanda S. Ramasamy |
Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
|
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
|
WO2001077091A2
(en)
|
2000-04-05 |
2001-10-18 |
Tularik Inc. |
Ns5b hcv polymerase inhibitors
|
|
KR100974917B1
(ko)
|
2000-04-13 |
2010-08-09 |
파마셋 인코포레이티드 |
간염 바이러스 감염 치료를 위한 3'- 또는2'-하이드록시메틸 치환된 뉴클레오시드 유도체
|
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
AU2001272923A1
(en)
*
|
2000-05-26 |
2001-12-11 |
Idenix (Cayman) Limited |
Methods and compositions for treating flaviviruses and pestiviruses
|
|
US6448281B1
(en)
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
|
CA2416748A1
(en)
|
2000-08-22 |
2002-02-28 |
Ribapharm Inc. |
Improved specificity in treatment of diseases
|
|
BR0113388A
(pt)
|
2000-08-22 |
2004-02-25 |
Ribapharm Inc |
Métodos de distribuição de drogas a hepatócitos e tratamento de infecções por flaviviridae
|
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
|
WO2002020497A1
(en)
|
2000-09-01 |
2002-03-14 |
Shionogi & Co., Ltd. |
Compounds having anti-hepatitis c virus effect
|
|
EP1411954B1
(en)
|
2000-10-18 |
2010-12-15 |
Pharmasset, Inc. |
Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
|
|
EP1343807B1
(en)
|
2000-12-12 |
2009-04-29 |
Schering Corporation |
Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
|
|
AU2002230763A1
(en)
|
2000-12-13 |
2008-01-03 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
|
WO2002048165A2
(en)
|
2000-12-15 |
2002-06-20 |
Pharmasset Ltd. |
Antiviral agents for treatment of flaviviridae infections
|
|
EP1346724A4
(en)
|
2000-12-26 |
2004-11-17 |
Mitsubishi Pharma Corp |
AGENT FOR TREATING HEPATITIS C
|
|
JP2004532184A
(ja)
*
|
2001-01-22 |
2004-10-21 |
メルク エンド カムパニー インコーポレーテッド |
Rna依存性rnaウィルスポリメラーゼ阻害薬としてのヌクレオシド誘導体
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
US20040191214A1
(en)
|
2001-06-15 |
2004-09-30 |
Johnson Lau |
Nucleoside vaccine adjuvants
|
|
GB0119369D0
(en)
|
2001-08-08 |
2001-10-03 |
Bookham Technology Plc |
Optic system
|
|
GB2378524A
(en)
|
2001-08-08 |
2003-02-12 |
Bookham Technology Plc |
Intergrated optic device
|
|
EP1435974A4
(en)
*
|
2001-09-28 |
2006-09-06 |
Idenix Cayman Ltd |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS C VIRUS USING 4 'MODIFIED NUCLEOSIDES
|
|
EP1438054A4
(en)
|
2001-09-28 |
2006-07-26 |
Idenix Cayman Ltd |
METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS AND PESTIVIRUS USING MODIFIED NUCLEOSIDE AT 4 'POSITION
|
|
US20030072451A1
(en)
|
2001-10-16 |
2003-04-17 |
Pimentel Roberto J. |
Method and apparatus for securely transferring wireless data
|
|
WO2003034709A1
(fr)
|
2001-10-17 |
2003-04-24 |
Naltec Inc. |
Procede de decompression et dispositif de traitement de donnees
|
|
WO2003037908A1
(en)
|
2001-10-31 |
2003-05-08 |
Ribapharm Inc. |
Antiviral combination therapy and compositions
|
|
AU2002353164A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Unusual nucleoside libraries, compounds, and preferred uses as antiviral and anticancer agents
|
|
WO2003051899A1
(en)
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Deazapurine nucleoside libraries and compounds
|
|
AU2002340387A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Cytidine libraries and compounds synthesized by solid-phase combinatorial strategies
|
|
WO2003051881A1
(en)
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies
|
|
AU2002357876A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Nucleoside analog libraries and compounds
|
|
AU2002349905A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Nucleoside libraries and compounds by mcc combinatorial strategies on solid support
|
|
US7261704B2
(en)
|
2001-12-28 |
2007-08-28 |
Terumo Kabushiki Kaisha |
Syringe
|
|
EP1572705A2
(en)
*
|
2002-01-17 |
2005-09-14 |
Ribapharm, Inc. |
Sugar modified nucleosides as viral replication inhibitors
|
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
|
US7323453B2
(en)
*
|
2002-02-13 |
2008-01-29 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
|
CA2484921A1
(en)
*
|
2002-05-06 |
2003-11-13 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis c virus infection
|
|
WO2004037161A2
(en)
*
|
2002-05-13 |
2004-05-06 |
Metabasis Therapeutics, Inc. |
Cyclic prodrugs of pmea one of its analogues
|
|
US7193081B2
(en)
*
|
2002-05-13 |
2007-03-20 |
Metabasis Therapeutics, Inc. |
Process for preparation of cyclic prodrugs of PMEA and PMPA
|
|
EP1572945A2
(en)
*
|
2002-06-27 |
2005-09-14 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
AP2005003211A0
(en)
|
2002-06-28 |
2005-03-31 |
Idenix Cayman Ltd |
1'-,2'-and 3'-modified nucleoside derivatives for treating flaviviridae infections.
|
|
KR20050035194A
(ko)
|
2002-06-28 |
2005-04-15 |
이데닉스 (케이만) 리미티드 |
플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
|
|
CA2490191C
(en)
|
2002-06-28 |
2010-08-03 |
Idenix (Cayman) Limited |
Modified 2' and 3' -nucleoside prodrugs for treating flaviviridae infections
|
|
WO2004007512A2
(en)
*
|
2002-07-16 |
2004-01-22 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
WO2004013300A2
(en)
|
2002-08-01 |
2004-02-12 |
Pharmasset Inc. |
Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections
|
|
NZ538457A
(en)
|
2002-09-30 |
2008-04-30 |
Genelabs Tech Inc |
Nucleoside derivatives for treating hepatitis C virus infection
|
|
WO2004041837A1
(en)
*
|
2002-10-31 |
2004-05-21 |
Metabasis Therapeutics, Inc. |
Novel cytarabine monophosphate prodrugs
|
|
CN1849142A
(zh)
|
2002-11-15 |
2006-10-18 |
埃迪尼克斯(开曼)有限公司 |
2′-支链核苷和黄病毒突变
|
|
TWI294882B
(en)
*
|
2002-12-09 |
2008-03-21 |
Hoffmann La Roche |
Anhydrous crystalline azido cytosine hemisulfate derivative
|
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
|
OA13315A
(en)
|
2003-10-14 |
2007-04-13 |
Intermune Inc |
Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication.
|
|
US7144868B2
(en)
*
|
2003-10-27 |
2006-12-05 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
|
JP2007509939A
(ja)
*
|
2003-10-27 |
2007-04-19 |
ジェネラブズ テクノロジーズ インコーポレーティッド |
ウイルス感染を治療するためのヌクレオシド化合物
|
|
US20050182252A1
(en)
*
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|